These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling. Yu WM; Hawley TS; Hawley RG; Qu CK Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078 [TBL] [Abstract][Full Text] [Related]
9. CD40-mediated regulation of interleukin-4 signaling pathways in B lymphocytes. Siepmann K; Wohlleben G; Gray D Eur J Immunol; 1996 Jul; 26(7):1544-52. PubMed ID: 8766559 [TBL] [Abstract][Full Text] [Related]
10. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway. Gorina R; Petegnief V; Chamorro A; Planas AM J Neurochem; 2005 Feb; 92(3):505-18. PubMed ID: 15659221 [TBL] [Abstract][Full Text] [Related]
11. [Long-term expansion of T cell progenitors by JAK3 gene transduced primitive hematopoietic cells in vitro]. Zhao SM; Gu XC; Chang NB; Xu XD; Peng MT Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1701-5. PubMed ID: 16854326 [TBL] [Abstract][Full Text] [Related]
13. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice. Wang S; Yang N; Zhang L; Huang B; Tan H; Liang Y; Li Y; Yu X Lupus; 2010 Sep; 19(10):1171-80. PubMed ID: 20501525 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. Bright JJ; Sriram S J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043 [TBL] [Abstract][Full Text] [Related]
17. [Inhibition of constitutively activated Jak3 and induction of apoptosis in NALM-6 cell line]. Hu W; Zhang C; Zhang P; Wei D; Zhao Z; Cai M Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):25-7. PubMed ID: 12599420 [TBL] [Abstract][Full Text] [Related]
18. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Lai TS; Liu Y; Tucker T; Daniel KR; Sane DC; Toone E; Burke JR; Strittmatter WJ; Greenberg CS Chem Biol; 2008 Sep; 15(9):969-78. PubMed ID: 18804034 [TBL] [Abstract][Full Text] [Related]
19. IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity. Das Gupta D; Paul C; Samel N; Bieringer M; Staudenraus D; Marini F; Raifer H; Menke L; Hansal L; Camara B; Roth E; Daum P; Wanzel M; Mernberger M; Nist A; Bauer UM; Helmprobst F; Buchholz M; Roth K; Bastian L; Hartmann AM; Baldus C; Ikuta K; Neubauer A; Burchert A; Jäck HM; Klein M; Bopp T; Stiewe T; Pagenstecher A; Lohoff M Cell Death Differ; 2022 Nov; 29(11):2163-2176. PubMed ID: 35459909 [TBL] [Abstract][Full Text] [Related]
20. The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors. Baskin R; Majumder A; Sayeski PP Curr Med Chem; 2010; 17(36):4551-8. PubMed ID: 21062251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]